GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TYR |
13.6895 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
12.8576 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
12.4836 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
12.2239 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
12.2239 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FLT3, SLC6A3, SRC, TEK, TYR |
10.8432 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SLC6A3, SRC, TEK, TYR |
10.4671 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
10.24 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
10.0512 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
9.90177 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, APP, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, TERT, XDH |
9.90177 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
9.86224 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP2, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
9.66451 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, SRC, TEK, XDH |
9.66451 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESRRB, F10, F3, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP1, TYR |
9.62072 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SLC6A3, SRC, TERT |
9.28236 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
9.23254 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
9.08008 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR |
8.95891 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX1, EPHX2, FABP3, FUT7, GLO1, HSPA1A, MIF, PIM1, PPARA, TYR, XDH |
8.76939 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CYP1B1, DRD2, DRD4, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, SRC, TEK, XDH |
8.76939 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.76939 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, EPHX2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PPARA |
8.76158 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
8.76144 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, SMAD3, SRC, TEK, TERT, XDH |
8.70431 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.66643 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, HSPA1A, SLC6A3 |
8.56531 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.36198 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
8.28234 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
8.12063 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, TEK, TERT |
7.83022 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TERT |
7.79284 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.77389 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.73832 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.64677 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.64677 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.45007 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, ADRA2C, APEX1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT |
7.43772 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
7.42677 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.30832 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, SRC, TEK |
7.20617 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
7.19025 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EPHX1, EPHX2, KDR, SLC6A3, SRC |
7.18465 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.12876 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
7.11607 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
7.09397 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.08469 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, SLC6A3, TYR |
7.05784 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.05031 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
6.87724 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.82432 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
6.74505 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, TYR |
6.67218 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
6.65605 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.64905 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, FABP3, KDR, SLC6A2, SLC6A3, SRC, TOP1 |
6.60713 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
6.47459 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC, TERT |
6.46147 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, ADRA2C, AKR1C3, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.45371 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
6.43031 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, INSR, SLC6A2, SLC6A3, SMAD3 |
6.26122 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
6.25928 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HSPA1A, KDR, MET, MIF, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK, TERT |
6.22469 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.21606 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
6.1107 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.09763 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
6.09763 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, ADRA2C, AKR1C3, APP, AURKB, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.06818 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.06818 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD17B1, HSD17B2 |
6.06818 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, ADRA2C, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.02165 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
6.00115 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.98157 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.92073 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
5.92073 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
5.90011 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT |
5.89659 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PPARA, SRC, TOP1, TOP2A |
5.86698 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
5.86228 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, MET, MIF, PPARA |
5.82388 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
5.82388 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, MIF, SRC, TERT |
5.73243 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
5.68685 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NUAK1, SMAD3, SRC, TERT, TOP2A |
5.68257 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.67144 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.67144 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3, DRD4 |
5.63974 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3, DRD4 |
5.63974 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX1, EPHX2, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
5.60398 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.57337 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP1, TOP2A, TYR, XDH |
5.53678 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, SLC6A3, SMAD3, TEK |
5.51593 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, SLC6A3, TERT |
5.42685 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.35341 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.29704 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
5.23321 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, SRC, TEK, XDH |
5.22146 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
5.21027 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
5.20747 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, SRC, TYR |
5.18729 |
[BP] GO:0065009 |
regulation of molecular function
|
ADRA2A, ADRA2C, APP, AURKB, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
5.17078 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
5.14086 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
5.14086 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, DRD4, EGFR, INSR, MIF, MMP12, SMAD3, SRC, TERT |
5.12819 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADRA2A, ADRA2C, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, XDH |
5.08775 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADRA2A, ADRA2C, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
5.08775 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
5.07212 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, SMAD3, SRC, TEK, XDH |
5.06942 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MIF, MMP9, SMAD3, SRC, TEK, XDH |
5.06942 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
5.06942 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
5.00864 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, ADRA2C, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT |
4.91919 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TERT, TYR |
4.91919 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
4.87487 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
4.82732 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, GPR35, SMAD3 |
4.80796 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3, SLC6A3 |
4.7778 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
4.7541 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.7468 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APEX1, APP, DRD1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
4.71863 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.65634 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.59368 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, XDH |
4.54198 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADRA2A, ADRA2C, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
4.53741 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AKR1C3, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
4.52241 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.52241 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, PPARA, SRC, TEK, XDH |
4.50243 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, ADRA2C, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
4.45428 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, DRD2, DRD4, EGFR |
4.42988 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.42675 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.39564 |
[BP] GO:0051952 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DRD4 |
4.36382 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
4.34413 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.25712 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, SRC |
4.24497 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
4.23309 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
4.23309 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, XDH |
4.22942 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP1, TOP2A |
4.22942 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, AKR1C3, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD4, EGFR, EPHX2, HSPA1A, MIF, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SMAD3, SRC, TEK, TERT, TOP2A |
4.18451 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APEX1, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, SRC |
4.18351 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
4.17255 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, ADRA2C, APP, AURKB, DRD2, DRD4, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT, XDH |
4.17255 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.17086 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.17086 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADRA2A, ADRA2C, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, XDH |
4.14638 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.14274 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TOP2A |
4.14025 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TERT, TOP2A |
4.11079 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, AKR1C3, CYP1A1, DRD3, EPHX2, FABP3, FLT3, PPARA, SRC, TEK |
4.08429 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, DRD1, DRD2, DRD3, MIF, PPARA, SLC6A3, SMAD3, TEK |
4.07635 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.07347 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.07347 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
4.03478 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CYP1A1, DRD3, DUSP3, INSR, TERT |
3.99342 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.99267 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
3.96245 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADRA2A, ADRA2C, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
3.94448 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADRA2A, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, KDR, MIF, SRC |
3.94321 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.89899 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, MIF, PPARA |
3.88987 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR |
3.83403 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR |
3.83403 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, MMP9, SRC, TEK, XDH |
3.81978 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, XDH |
3.81837 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, MIF |
3.81133 |
[BP] GO:0003018 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2, SRC, TEK |
3.81133 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.80708 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, AKR1C3, APEX1, APP, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
3.79504 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.78266 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.7666 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.7666 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.7666 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9, TERT |
3.73986 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
3.73716 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
3.71319 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
3.69187 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, EGFR, ESRRB, FLT3, INSR, KDR, MIF, MMP9, SRC, TEK, XDH |
3.68511 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADRA2A, ADRA2C, APP, AURKB, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, MIF, SMAD3, SRC, TEK, TERT, XDH |
3.66878 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.65905 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, SRC, XDH |
3.6397 |
[BP] GO:0055080 |
cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
3.63003 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
3.62618 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.62618 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.62618 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.62618 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
3.62618 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
3.62552 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, MIF, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
3.6147 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.58526 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADRA2A, ADRA2C, APP, AURKB, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
3.58213 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
3.58213 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADRA2A, ADRA2C, APP, DRD1, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, SRC, TEK, XDH |
3.56921 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APEX1, APP, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
3.54437 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
3.53906 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, ADRA2C, APP, CSNK2A1, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, SMAD3, SRC, TEK, XDH |
3.53428 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
3.53172 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.53172 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.51023 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX1, EPHX2 |
3.50223 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIM1, SRC, TEK, TYR |
3.49132 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
3.49107 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, APP, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
3.49061 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.49061 |
[BP] GO:0001666 |
response to hypoxia
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.43495 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.42994 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC |
3.41888 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
3.41603 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.41393 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.41393 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
3.40591 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.38335 |
[BP] GO:0002791 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
3.38126 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1 |
3.37985 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, AKR1C3, APP, AXL, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD17B2, INSR, MMP2, MMP9, SRC, TOP2A |
3.37797 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.36862 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.36337 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.36337 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.36251 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.34063 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.33168 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.33168 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.32489 |
[BP] GO:0090087 |
None
|
ACHE, ADRA2A, ADRA2C, APP, CA2, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SMAD3, SRC |
3.31387 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MIF, MMP9, SMAD3, SRC, TEK, XDH |
3.31387 |
[BP] GO:0007189 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3 |
3.3107 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.3107 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.30508 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, SRC, TEK, XDH |
3.30484 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX1, EPHX2, FABP3, FABP4, HSPA1A, SLC6A3, SRC, XDH |
3.30198 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CYP1A1, DRD2, DRD3, INSR, TERT |
3.30046 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, KDR, MIF, SRC, TEK |
3.30046 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.28875 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.28875 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.26808 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, KDR, MIF, SRC, TEK |
3.26808 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.25873 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.24665 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.24665 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
3.22712 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
3.22281 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
3.21768 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PPARA |
3.21582 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.20947 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, APP, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, INSR, KDR, PIM1, SLC6A3, SMAD3, SRC, TEK, TERT |
3.18864 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, DRD1, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.18166 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.17868 |
[BP] GO:0003013 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2, SRC, TEK |
3.17847 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
3.17847 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.16954 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, MIF, TERT |
3.16828 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
3.16427 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A3 |
3.16285 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, APP, AXL, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MIF, MMP2, MMP9, SMAD3, SRC, TEK, TERT, TOP2A |
3.16285 |
[BP] GO:0070482 |
response to oxygen levels
|
CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.15067 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
3.1472 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD4 |
3.13323 |
[BP] GO:0043269 |
regulation of ion transport
|
ADRA2A, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, GPR35, MIF, MMP9 |
3.11591 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, DRD4, PPARA |
3.09911 |
[BP] GO:1901020 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
3.09476 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.09476 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.08553 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC |
3.0799 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.07235 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
3.07235 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.07235 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.07235 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.07235 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.07235 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.07235 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
3.06829 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, APP, CSNK2A1, DRD1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.04681 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD4, EGFR, SLC6A3 |
3.01904 |
[BP] GO:0042058 |
None
|
ADRA2A, ADRA2C, APP, EGFR, MMP9 |
3.01628 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
3.01628 |
[BP] GO:0032412 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.0004 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, SRC, TEK |
3.0004 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.99183 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.9899 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, APP, CSNK2A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SMAD3, SRC, TERT |
2.9853 |
[BP] GO:0051254 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
2.9833 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
2.97648 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR |
2.96207 |
[BP] GO:1903170 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.96207 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.96207 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, DRD4, MET |
2.95882 |
[BP] GO:0022898 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.93999 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, SMAD3, XDH |
2.93768 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.92904 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, DRD1, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
2.92904 |
[BP] GO:0019933 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3 |
2.91924 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.91392 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A3 |
2.91392 |
[BP] GO:0050730 |
None
|
ADRA2A, ADRA2C, APP, EGFR, FLT3, MIF, SRC |
2.9132 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.89846 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.89846 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD4 |
2.89846 |
[BP] GO:0007188 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DRD4 |
2.88954 |
[BP] GO:0040008 |
regulation of growth
|
APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A3, SMAD3 |
2.88954 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.88954 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, APP, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SMAD3, SRC |
2.87616 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3, EGFR, KDR |
2.87483 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.87326 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, HSD17B2, HSPA1A, PPARA, SLC6A3, SMAD3, TERT, TOP1, TOP2A, TYR, XDH |
2.87013 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.8696 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, SRC |
2.86558 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.86142 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
2.85716 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, MIF, NUAK1, SRC, TEK |
2.85191 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.84727 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.84727 |
[BP] GO:0050433 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.84142 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, SMAD3 |
2.83486 |
[BP] GO:0051591 |
None
|
APEX1, APP, SLC6A3, TEK, TYR |
2.83486 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, SLC6A3, TYR |
2.81905 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, FLT3, INSR, MIF, SRC, TEK |
2.81905 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.81763 |
[BP] GO:0032409 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.81501 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.81501 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.81501 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.80189 |
[BP] GO:0042752 |
None
|
DRD2, DRD3, DRD4, PPARA, TOP2A |
2.80189 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, APP, AXL, CYP1A1, DRD3, DRD4, EGFR, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC, TOP1 |
2.80189 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, CA2, DRD1, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.80189 |
[BP] GO:0003008 |
None
|
ADRA2A, ADRA2C, AKR1B1, AKR1C3, APP, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, INSR, SLC6A3, SRC, TEK, TYR |
2.79928 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, MIF |
2.79665 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.78923 |
[BP] GO:2000351 |
None
|
AKR1C3, KDR, TEK, TERT |
2.78923 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.78923 |
[BP] GO:1901184 |
None
|
ADRA2A, ADRA2C, APP, EGFR, MMP9 |
2.78923 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.78756 |
[BP] GO:1901575 |
None
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2, FABP3, FABP4, FUT7, HSPA1A, SLC6A3, XDH |
2.78255 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
2.77251 |
[BP] GO:0019935 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3 |
2.77251 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.76666 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.76174 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, INSR, KDR, PIM1, SMAD3, SRC, TEK, TERT, XDH |
2.76166 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.76166 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.76024 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.76024 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.76024 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.76024 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.75846 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, APEX1, EGFR, ESR1, FLT3, INSR, SRC |
2.75846 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, DRD2, DRD4, EGFR, FLT3, INSR, MIF, SRC, TEK |
2.75171 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.75038 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
2.74593 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.7412 |
[BP] GO:0045893 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
2.73273 |
[BP] GO:1903508 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
2.73273 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.73179 |
[BP] GO:1902680 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT, TOP2A |
2.73107 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, SMAD3, SRC |
2.73001 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.73001 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, EPHX2, HSPA1A, SLC6A3, XDH |
2.72213 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.71887 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, APP, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SMAD3, SRC |
2.71887 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.71792 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.71528 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.71528 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.71528 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.71528 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.71528 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.71528 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.71528 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.69805 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.69805 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.69188 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, SMAD3, SRC, TERT |
2.6867 |
[BP] GO:0042069 |
None
|
DRD1, DRD4, SLC6A3 |
2.68339 |
[BP] GO:0042053 |
None
|
DRD1, DRD4, SLC6A3 |
2.68339 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.67267 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.67267 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.65982 |
[BP] GO:0009611 |
response to wounding
|
ACHE, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
2.64683 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
2.64683 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, TOP1 |
2.64589 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, SRC |
2.64297 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.62454 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.61234 |
[BP] GO:0007187 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DRD4 |
2.60004 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.59115 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.58798 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, DRD4, FABP3, PPARA, SLC6A2, SLC6A3 |
2.58583 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.57962 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADRA2A, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TERT, TOP2A |
2.57667 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A3 |
2.56815 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, SMAD3 |
2.54505 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.5432 |
[BP] GO:0051046 |
None
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MIF, MMP12, SRC |
2.5385 |
[BP] GO:0030814 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.53414 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADRA2A, ADRA2C, APP, CSNK2A1, DRD1, DRD2, DRD4, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.53096 |
[BP] GO:0051234 |
None
|
ACHE, ADRA2A, AKR1C3, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, DRD4, EGFR, F10, FABP3, HSPA1A, MIF, MMP12, MMP9, PPARA, SLC6A2, SLC6A3, SRC, TERT, XDH |
2.52714 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.51574 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.51574 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.51504 |
[BP] GO:0051179 |
None
|
ACHE, ADRA2A, AKR1C3, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, HSPA1A, MIF, MMP12, MMP9, PPARA, SLC6A2, SLC6A3, SRC, TERT, XDH |
2.51504 |
[BP] GO:0051047 |
None
|
ACHE, CYP19A1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
2.49618 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.49618 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.49618 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.49308 |
[BP] GO:0030802 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.49308 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.49308 |
[BP] GO:0051051 |
negative regulation of transport
|
ADRA2A, ADRA2C, APP, DRD2, DRD3, DRD4, GPR35, HSPA1A, MMP9 |
2.48579 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.47855 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.47795 |
[BP] GO:0051953 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.47795 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.47795 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.47795 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.47795 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, TYR |
2.47795 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.47795 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.47795 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.47795 |
[BP] GO:0097176 |
epoxide metabolic process
|
EPHX1, EPHX2 |
2.47795 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.47795 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.47795 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.47795 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
2.45925 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, XDH |
2.45925 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.44678 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, DRD2, DRD3, DRD4, HSPA1A, MIF, MMP9, SLC6A3, XDH |
2.44123 |
[BP] GO:0097746 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2 |
2.43512 |
[BP] GO:0035296 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2 |
2.43512 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.43512 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.43512 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43512 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, MIF, MMP12, SMAD3, SRC |
2.42828 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.4233 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.4233 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, DRD2, DRD4, GPR35 |
2.4233 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.4233 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADRA2A, ADRA2C, APP, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MIF, MMP9, SRC, TEK, XDH |
2.40121 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, FLT3, INSR, MIF, SRC |
2.40121 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.38821 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.37912 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.3784 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, DRD2, DRD3, SLC6A3 |
2.37756 |
[BP] GO:1900371 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.36563 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, INSR, SRC |
2.35783 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADRA2A, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSPA1A, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TERT, TOP2A |
2.35766 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.3563 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, APP, AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.3563 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, SMAD3, SRC, TERT |
2.3563 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, SLC6A3, TEK, TYR |
2.3563 |
[BP] GO:0030808 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.3563 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, TERT, XDH |
2.35068 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.35068 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.35068 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.35068 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.35068 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.33146 |
[BP] GO:0050880 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2 |
2.33146 |
[BP] GO:0010468 |
regulation of gene expression
|
APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, INSR, KDR, MET, MIF, MMP12, PIM1, PPARA, SMAD3, SRC, TERT, TOP1, TOP2A, XDH |
2.31938 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.31938 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.31938 |
[BP] GO:0035150 |
None
|
ADRA2A, ADRA2C, DRD1, EGFR, EPHX2 |
2.31919 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.31132 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.30808 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.30808 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.30808 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.30808 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.30808 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.30808 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.30808 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.30808 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.30808 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.30808 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, PPARA, TOP1 |
2.28915 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, INSR |
2.28915 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.28877 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, DRD4, EGFR, INSR, PPARA, SLC6A3 |
2.27641 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.27569 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, INSR, SRC |
2.27569 |
[BP] GO:0045944 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, MET, MMP12, PPARA, SMAD3, TERT, TOP2A |
2.27312 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.26926 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.26689 |
[BP] GO:0034765 |
None
|
ADRA2A, APP, DRD1, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.25035 |
[BP] GO:0071383 |
None
|
AKR1C3, EGFR, FLT3, SRC |
2.24931 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.23777 |
[BP] GO:0007176 |
None
|
ADRA2A, ADRA2C, APP |
2.23777 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.23777 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TOP2A |
2.23177 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
2.22461 |
[BP] GO:0030799 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD4 |
2.21552 |
[BP] GO:1903169 |
None
|
ADRA2A, DRD1, DRD2, DRD4, GPR35 |
2.21552 |
[BP] GO:0007193 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.21327 |
[BP] GO:1904035 |
regulation of epithelial cell apoptotic process
|
AKR1C3, KDR, TEK, TERT |
2.21327 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.21327 |
[BP] GO:0006357 |
None
|
APP, AURKB, CA9, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GLO1, HSPA1A, MET, MMP12, PPARA, SMAD3, TERT, TOP2A |
2.20898 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.20766 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.20194 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.20194 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.20194 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, SMAD3, SRC, TEK |
2.17647 |
[BP] GO:0008344 |
None
|
APP, DRD1, DRD2, DRD4 |
2.17586 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, SLC6A3, TEK, TYR |
2.17586 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, CYP1A1, MIF, SLC6A3, TERT |
2.17586 |
[BP] GO:0050678 |
None
|
EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.17586 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.17586 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.17586 |
[BP] GO:2000352 |
None
|
KDR, TEK, TERT |
2.17586 |
[BP] GO:0010039 |
response to iron ion
|
CYP1A1, DRD2, SLC6A3 |
2.17586 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.17586 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.17586 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.17586 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.17586 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.17586 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.17586 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.17586 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.17586 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.17586 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.17586 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.17586 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.17586 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.17586 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.17586 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.17586 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.17381 |
[BP] GO:0008217 |
None
|
DRD2, DRD3, EPHX2, PPARA, SMAD3 |
2.14723 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, MIF, MMP12, SRC |
2.14486 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, EGFR, INSR |
2.14486 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.14331 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.14331 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.13746 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13746 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, APP, AURKB, AXL, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP1, TOP2A |
2.13746 |
[BP] GO:2001257 |
None
|
APP, DRD2, DRD4, GPR35, MMP9 |
2.12578 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.1189 |
[BP] GO:0031327 |
None
|
ADRA2A, AKR1C3, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, SMAD3, SRC |
2.11428 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.10916 |
[BP] GO:1902893 |
None
|
PPARA, SMAD3, TERT |
2.10916 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.10916 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADRA2A, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TERT, TOP2A |
2.09393 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, TEK, TERT |
2.09086 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.08904 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.08635 |
[BP] GO:1901989 |
None
|
APEX1, APP, CYP1A1, TERT |
2.08469 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.0648 |
[BP] GO:0009890 |
None
|
ADRA2A, AKR1C3, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, SMAD3, SRC |
2.06284 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.0616 |
[BP] GO:0040016 |
embryonic cleavage
|
TOP1, TOP2A |
2.0543 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP3A4 |
2.0543 |
[BP] GO:0032226 |
None
|
DRD2, DRD4 |
2.0543 |
[BP] GO:0098810 |
None
|
SLC6A2, SLC6A3 |
2.0543 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, MIF, SRC |
2.04297 |
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, XDH |
2.03985 |
[BP] GO:0007200 |
None
|
ADRA2A, DRD1, DRD2, ESR1 |
2.03936 |
[BP] GO:1901019 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.03936 |
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, XDH |
2.03641 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.03055 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.01838 |
[BP] GO:1901385 |
None
|
DRD2, DRD4, GPR35 |
2.01678 |
[BP] GO:1900087 |
None
|
APEX1, CYP1A1, TERT |
2.01678 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.01678 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, MIF, MMP12, SRC |
2.01357 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.01016 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, AXL, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.01013 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADRA2A, ADRA2C, APP, AXL, CA4, DRD1, DRD2, DRD3, DRD4, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
4.65758 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADRA2A, ADRA2C, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, F3, FLT3, GLO1, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT |
3.65905 |
[CC] GO:0044459 |
plasma membrane part
|
ADRA2A, ADRA2C, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, SRC, TEK |
3.50735 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, MET, MIF, SLC6A2, SLC6A3, TEK |
3.49061 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADRA2A, ADRA2C, APP, AXL, DRD1, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
3.22281 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
3.13323 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
3.11591 |
[CC] GO:0009330 |
None
|
TOP1, TOP2A |
3.07235 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADRA2C, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TERT, TOP1, TOP2A, TYR, XDH |
2.75038 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.69188 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.62454 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.56815 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADRA2C, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MIF, MMP2, MMP9, PIM1, SMAD3, SRC, TERT, TOP1, TOP2A, TYR, XDH |
2.56815 |
[CC] GO:0016020 |
membrane
|
ACHE, ADRA2A, ADRA2C, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, F10, F3, FLT3, FUT7, GLO1, GPR35, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TYR |
2.16691 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
14.5523 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TYR, XDH |
12.988 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1246 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, EPHX1, EPHX2, F10, F3, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK, TERT, TOP1, TOP2A, TYR, XDH |
9.92818 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
9.30958 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, TERT, TOP2A, TYR, XDH |
9.06973 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A3, SRC, TEK, TOP1, TOP2A |
8.76144 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.54969 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.98773 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.82432 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD4, SLC6A3 |
6.64905 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.47293 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, TERT, TOP2A, TYR, XDH |
6.34289 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
6.06153 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, APP, CSNK2A1, DRD2, DRD4, EGFR, EPHX2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MIF, MMP9, SMAD3, TERT, TOP2A, TYR, XDH |
5.833 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
5.68928 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.46173 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.44443 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.39026 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.20872 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
5.13859 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
5.06829 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC |
5.00384 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.91919 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.91919 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD4 |
4.91919 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
4.8853 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.76822 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC |
4.73223 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.72101 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD4, SLC6A3 |
4.45532 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.18159 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.14638 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD17B1, HSD17B2, XDH |
4.14025 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
4.09593 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.08429 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.99267 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.99267 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.81133 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.69355 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.64392 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, DRD4 |
3.62618 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.62618 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TERT, TOP1 |
3.59833 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.49061 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.49061 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADRA2A, ADRA2C, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TERT, TOP1, TOP2A, XDH |
3.46426 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1, PPARA |
3.37682 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.2764 |
[MF] GO:0005102 |
receptor binding
|
ADRA2A, ADRA2C, APP, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, SLC6A3, SMAD3, SRC |
3.27596 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
3.22712 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADRA2A, ADRA2C, AXL, DRD1, DRD2, DRD3, DRD4, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
3.22712 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.13073 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.07235 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.07235 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.03722 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A, XDH |
2.96918 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AURKB, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, MIF, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A |
2.92904 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.84727 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, DRD2, EPHX2, FLT3, SMAD3, TERT, TOP2A, TYR, XDH |
2.834 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.71528 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.71528 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.71528 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.71528 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.65982 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.62454 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.55616 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A |
2.55616 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK, TOP1 |
2.54505 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD17B1, HSD17B2 |
2.49308 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.48523 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.47795 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.47795 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.47795 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.47795 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A |
2.46973 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.46391 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A |
2.44092 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A, XDH |
2.40121 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.3563 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.35068 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A, XDH |
2.31318 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1, TOP2A, XDH |
2.31132 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.30855 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.30808 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.30808 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.30808 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.30808 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, AXL, DRD2, EGFR, EPHX2, FLT3, SMAD3, TERT, TOP2A, TYR, XDH |
2.26496 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.23777 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.23777 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.17586 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.17586 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.17586 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.17586 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.17586 |
[MF] GO:0004301 |
None
|
EPHX1, EPHX2 |
2.17586 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.07486 |
[MF] GO:0016709 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
|
AKR1C3, CYP1A1, CYP3A4 |
2.07486 |
[MF] GO:0003916 |
None
|
TOP1, TOP2A |
2.0543 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.0543 |
[MF] GO:0001758 |
None
|
AKR1B10, AKR1C3 |
2.0543 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1 |
2.0543 |
[MF] GO:0004032 |
None
|
AKR1B1, AKR1C3 |
2.0543 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, ESR1, ESRRB, FLT3, PIM1, PPARA, SMAD3, SRC, TERT |
2.05411 |
[MF] GO:0004252 |
None
|
F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.04115 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC |
2.02228 |